【24h】

Combination of endostatin gene transfer and radiation therapy against lung adenocarcinoma model

机译:内皮抑素基因转移与放射治疗联合治疗肺腺癌模型

获取原文

摘要

To investigate the combined effects of endostatin gene therapy and radiation in lung adenaocarcinoma model. Human lung adenocarcinoma A549 cell line was transfected with retroviral vector pLESSN which encoded endostatin gene to obtain A549/Endo cells. PCR amplification was used to verify the endostatin gene in the DNA of A549/Endo cells. The transfectant A549/Endo cell's growth in vitro was estimated by cell counting assay. And the inhibitive effect of expressed endostatin on the proliferation of endothelial cell EA.hy926 in vitro was assayed by MTT method. In vivo study, the nude mouse subcutaneous tumor growths of 4 groups (A549, A549/Endo, A549+irradiation, A549/Endo+irradiation) were observed and compared. And the microvessel density (MVD) of each of 4 group tumors was assayed with Immunohistochemical analysis. PCR confirmed that there was a 600-bp endostatin gene fragment in the DNA of A549/Endo cells, but not in the DNA of A549 cells. Cell counting assay showed that there was no cell-proliferation difference between A549/Endo cells and A549 cells in vitro. MTT assay revealed that the expressed product of endostatin gene could significantly inhibit the proliferation of endothelial cells EA.hy926 in vitro by 47.3%. Tumor growth of A549/Endo cells was delayed significantly compared with A549 cells (p<0.01). Although radiation had a definite effect on A549 tumors, the tumor growth inhibitive effect of endostatin gene transfer plus radiation was greater than any their alone therapy (p<0.01,respectively). The results of immunohistochemical detection showed that the MVD of A549/Endo and A549/Endo+Irradiation tumor were both significantly decreased compared with A549 tumor(p<0.01, respectively). But further compared between A549/Endo and A549/Endo+Irradiation tumor, the MVD of A549/Endo+Irradiation tumor was further significant declined (p<0.01). Retrovirus vector can effectively transfer endostatin gene into A549 cells. Endostatin gene transfer combined with radiation has a synergistical inhibition effect on the growth of lung adenocarcinoma tumor model.
机译:探讨内皮抑素基因治疗与放射治疗在肺腺癌模型中的联合作用。用编码内皮抑素基因的逆转录病毒载体pLESSN转染人肺腺癌A549细胞,得到A549 / Endo细胞。 PCR扩增用于验证A549 / Endo细胞DNA中的内皮抑素基因。通过细胞计数测定来估计转染子A549 / Endo细胞的体外生长。 MTT法检测内皮抑素表达对体外培养的内皮细胞EA.hy926增殖的抑制作用。在体内研究中,观察并比较了4组裸鼠皮下肿瘤的生长情况(A549,A549 / Endo,A549 +放射,A549 / Endo +放射)。并用免疫组织化学方法检测4组肿瘤的微血管密度(MVD)。 PCR证实在A549 / Endo细胞的DNA中有一个600bp的内皮抑素基因片段,但在A549细胞的DNA中没有。细胞计数试验表明,体外培养的A549 / Endo细胞与A549细胞之间无细胞增殖差异。 MTT法检测内皮抑素基因的表达产物在体外能显着抑制内皮细胞EA.hy926的增殖,达47.3%。与A549细胞相比,A549 / Endo细胞的肿瘤生长明显延迟(p <0.01)。尽管放疗对A549肿瘤具有明确的作用,但内皮抑素基因转移加放疗对肿瘤生长的抑制作用要比其单独治疗更大(分别为p <0.01)。免疫组织化学检测结果表明,与A549肿瘤相比,A549 / Endo和A549 / Endo +放射肿瘤的MVD均显着降低(分别为p <0.01)。但进一步比较A549 / Endo和A549 / Endo +辐照肿瘤后,A549 / Endo +辐照肿瘤的MVD进一步显着下降(p <0.01)。逆转录病毒载体可以有效地将内皮抑素基因转移到A549细胞中。内皮抑素基因转移与放射结合对肺腺癌肿瘤模型的生长具有协同抑制作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号